menu
    • menu

    Company profile for ChemRar

    NEW Drugs in Dev: 2
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ChemRar Group unites R&D service and investment companies in the field of innovative pharmaceuticals for the development and commercialization of innovative medicines, diagnostics, preventive care and new treatments of life-threatening diseases in Russia and abroad. Mission of ChemRar Group: Improve the quality of life by creating novel medicines. We develop and manufacture effective, safe and affordable medicines for th...
    ChemRar Group unites R&D service and investment companies in the field of innovative pharmaceuticals for the development and commercialization of innovative medicines, diagnostics, preventive care and new treatments of life-threatening diseases in Russia and abroad. Mission of ChemRar Group: Improve the quality of life by creating novel medicines. We develop and manufacture effective, safe and affordable medicines for the treatment of socially significant diseases and improvement of the quality of life: Using experience and global standards at all stages of creation of a novel medicine

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ChemRarRussia-big Flag
    Country
    Country
    Russia
    Address
    Address
    2a-1, Rabochaya St. Khimki, Moscow region, 141400
    Telephone
    Telephone
    +7 (495) 925-30-74
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://en.chemrar.ru/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/chemrar

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    International Sweetener Colloquium

    Not Confirmed

    envelop Contact Supplier

    International Sweetener Colloquium

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Russia to supply 17 more countries with COVID-19 drug Avifavir
    Russia to supply 17 more countries with COVID-19 drug Avifavir

    25 Sep 2020

    // Andrew Osborn REUTERS

    https://www.reuters.com/article/us-health-coronavirus-russia-drug/russia-to-supply-17-more-countries-with-covid-19-drug-avifavir-idUSKCN26F12S

    Andrew Osborn REUTERS
    25 Sep 2020
    Share Share
    Russia’s RDIF, ChemRar to boost production of Avifavir for Covid-19
    Russia’s RDIF, ChemRar to boost production of Avifavir for Covid-19

    03 Jul 2020

    // PHARMACEUTICAL-TECHNOLOGY

    https://www.pharmaceutical-technology.com/news/avifavir-covid-19-production/

    PHARMACEUTICAL-TECHNOLOGY
    03 Jul 2020
    Share Share
    Russia rolls out first approved COVID-19 drug as infections pass 500,000
    Russia rolls out first approved COVID-19 drug as infections pass 500,000

    11 Jun 2020

    // REUTERS

    https://www.reuters.com/article/us-health-coronavirus-russia-cases/russia-rolls-out-first-approved-covid-19-drug-as-infections-pass-500000-idUSKBN23I0YY?feedType=RSS&feedName=healthNews

    REUTERS
    11 Jun 2020
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search